Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General cellular thiol groups, primarily represented by the tripeptide glutathione (GSH) and cysteine residues within proteins, constitute the fundamental redox buffer of the cell (Source: PMCID: PMC3549305). These sulfhydryl-containing molecules are essential for maintaining cellular homeostasis by scavenging reactive oxygen and nitrogen species, thereby protecting DNA, lipids, and proteins from oxidative damage (Source: PMCID: PMC2696075). Beyond their protective role, thiols are involved in critical biological processes such as protein folding via disulfide bond formation and the regulation of signaling pathways through reversible modifications like S-glutathionylation. In clinical practice, these groups are targeted by drugs like N-acetylcysteine to replenish antioxidant stores during oxidative stress or acetaminophen overdose (Source: StatPearls, N-Acetylcysteine). Conversely, certain chemotherapeutics and heavy metals exert toxicity by depleting or binding to these thiol groups, leading to cellular dysfunction or apoptosis (Source: PMCID: PMC3146111). Because thiols are ubiquitous across all cell types, therapeutic strategies involving them must carefully balance the restoration of redox balance against the risk of non-specific off-target effects.
Drugs interact with cellular thiols through redox-mediated scavenging of reactive species, covalent modification (alkylation), or coordination with metal ions to modulate cellular antioxidant capacity or neutralize toxins (Source: StatPearls, N-Acetylcysteine; PMCID: PMC3549305).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General cellular thiol groups (R-SH).